Remove Cardiology Remove Clinical Trials Remove Genotype
article thumbnail

Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis

Scienmag

The fully human monoclonal antibody produced sustained reductions in triglyceride levels of up to 82 percent, depending on the patient’s genotype, while also lowering the […].

article thumbnail

HFpEF vs. HFrEF: How To Improve Heart Failure Drug Development

XTalks

Late-stage clinical trial failures are largely to blame for the lack of effective treatment options for patients with HFpEF, and poor five-year survival rates make this an area of great unmet need. And by validating a drug target before further developing target compounds, late-stage clinical trial attrition could be greatly decreased.